×
Atossa Genetics EBIT 2012-2024 | ATOS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Atossa Genetics ebit from 2012 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
Atossa Genetics EBIT 2012-2024 | ATOS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Atossa Genetics ebit from 2012 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$211B
Intuitive Surgical (ISRG)
$191.1B
Alcon (ALC)
$45.7B
IQVIA Holdings (IQV)
$39.8B
Edwards Lifesciences (EW)
$39.1B
IDEXX Laboratories (IDXX)
$35.5B
DexCom (DXCM)
$27.3B
Waters (WAT)
$22.8B
SONOVA HOLDING (SONVY)
$22.1B
STERIS (STE)
$21.6B
Hologic (HOLX)
$18.3B
Sysmex ADR (SSMXY)
$12.9B
Fresenius Medical Care AG KGaA (FMS)
$12.5B
Globus Medical (GMED)
$11B
Teleflex (TFX)
$9.1B
Penumbra (PEN)
$9.1B
Masimo (MASI)
$8.7B
Glaukos (GKOS)
$7.8B
PROCEPT BioRobotics (PRCT)
$5.2B
Integer Holdings (ITGR)
$4.6B
Inari Medical (NARI)
$3B
TransMedics (TMDX)
$2.9B
LivaNova (LIVN)
$2.8B
Veracyte (VCYT)
$2.8B
Nihon Kohden (NHNKY)
$2.6B
Elekta AB (EKTAY)
$2.3B
Tandem Diabetes Care (TNDM)
$2B
Integra LifeSciences Holdings (IART)
$1.9B
RxSight (RXST)
$1.8B
Alphatec Holdings (ATEC)
$1.3B